yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q36491239-4E66EA4F-E943-4873-86C6-EF0DB12DC795
Q36491239-4E66EA4F-E943-4873-86C6-EF0DB12DC795
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36491239-4E66EA4F-E943-4873-86C6-EF0DB12DC795
Randomized trial of adjuvant thalidomide versus observation in patients with completely resected high-risk renal cell carcinoma.
P2860
Q36491239-4E66EA4F-E943-4873-86C6-EF0DB12DC795
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36491239-4E66EA4F-E943-4873-86C6-EF0DB12DC795
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3725c08d1120247b1519f68d2e6949b83d40a881
P2860
Thalidomide down-regulates the expression of VEGF and bFGF in cisplatin-resistant human lung carcinoma cells.